106
Participants
Start Date
April 30, 2008
Primary Completion Date
March 31, 2010
Study Completion Date
March 31, 2010
Reslizumab
Saline
Health Sciences Research at Asthma & Allergy, Cortland
University of Pittsburgh, Pittsburgh
Allergy and Asthma Specialists, Blue Bell
Pulmonary Disease & Critical Care Associates, P.A., Columbia
Virginia Adult & Pediatric Allergy and Asthma, Richmond
Virginia Commonwealth University, Richmond
Wake Forest Univeristy Health Services, Winston-Salem
Vanderbilt Asthma Sinus Allergy Program & Research Centers, Nashville
Toledo Center for Clinical Research, Sylvania
David Bernstein, Cincinnati
Allergy, Asthma and Sinus Center, Greenfield
University of Wisconsin-Madison, Allergy/Asthma Clinical Research Unit, Madison
Clinical Research Institute, Minneapolis
Sneeze, Wheeze & Itch Associates, LLC, Normal
Washington University of School of Medicine, St Louis
The Asthma & Allergy Center, Papillion
Allergy, Asthma and Clinical Research Center, Oklahoma City
Allergy & Clinical Research Center, Centennial
National Jewish Medical & Research Center, Denver
Asthma & Allergy Associates, P.C., Colorado Springs
Children'S Hospital of Orange County-Pediatric Subspecialty Faculty, Orange
Clinical Research Institute of Southern Oregon, Medford
Asthma, Inc, Seatle
Brigham and Women's Hospital, Boston
Heritage Medical Research Clinic, University of Calgary, Calgary
St. Joseph's Healthcare, Hamilton
Queen's University, Richardson's House, Kingston
The Ottawa Hospital, Ottawa
Hopital du Sacre-Couer de Montreal, Montreal
Hopital Laval, Québec
Lead Sponsor
Collaborators (1)
Cephalon
INDUSTRY
Ception Therapeutics
INDUSTRY